References
- Neil GA, Lukie BE, Cockcroft DW, Murphy F. Lymphocytic interstitial pneumonia and abdominal lymphoma complicating celiac sprue.J Clin Gastroenterol 1986;8:282–5.
- Hood J, Mason AM. Diffuse pulmonary disease with transfer defect occurring with coeliac disease. Lancet 1970;1: 445–7.
- Smith MJ, Benson MK, Strickland ID. Coeliac disease and diffuse interstitial lung disease. Lancet 1971;1:473–5.
- Ben-Bassat O, Lev S, Gafter-Gvili A, Katchman E, Niv Y, Fraser GM. Acute pneumonitis in a patient with celiac disease and dermatitis herpetiformis. Isr Med Assoc J 2005; 7:340–1.
- Oh K, Park H-B, Byoun O-J, Shin D-M, Jeong EM, Kim YW, . Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med 2011;208:1707–19.
- Westermann W, Schöbl R, Rieber EP, Frank KH. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol 1999;75:629–38.
- Johnston CJ, Williams JP, Elder A, Hernady E, Finkelstein JN. Inflammatory cell recruitment following thoracic irradiation. Exp Lung Res 2004;30:369–82.
- Cappuccini F, Eldh T, Bruder D, Gereke M, Jastrow H, Schulze-Osthoff K, . New insights into the molecular pathology of radiation-induced pneumopathy. Radiother Oncol 2011;101:86–92.
- Shaoul R, Lerner A. Associated autoantibodies in celiac disease. Autoimmun Rev 2007;6:559–65.
- Lewis NR, Holmes GKT. Risk of morbidity in contemporary celiac disease. Expert Rev Gastroenterol Hepatol 2010;4: 767–80.
- Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GVW, . Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med 2011; 184:699–707.
- Barker JM, Liu E. Celiac disease: Pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr 2008;55:349–65.
- Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, . Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial. J Thorac Oncol 2008;3:994–1002.